Is it time to buy British American Tobacco after today’s news?

Does last year’s acquisition of Reynolds American make British American Tobacco plc (LON:BATS) a buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Smoking may be falling out of favour in most western countries, but until recently, tobacco stocks have remained very popular.

That situation has reversed over the last year, during which British American Tobacco (LSE: BATS) stock has fallen by 12% against a flat FTSE 100.

The situation worsened this morning, when shares in British American fell after the group’s 2017 results were published. Although shareholders will be pleased with a 15% dividend hike, City analysts noted that full-year sales were slightly below market forecasts.

Increased market share

BAT completed the £41.8bn acquisition of US rival Reynolds American Inc in July last year. This massive deal means the firm’s figures for the year are hard to compare with those from 2016.

However, the company says that after stripping out the impact of the acquisition and of currency exchange rates, sales rose by 2.9% to £15,173m last year, while adjusted earnings rose by 9.9% to 272.1p.

The dividend was increased by 15.2% to 195.2p per share, beating broker forecasts for a payout of 183.8p per share.

Although the firm’s tobacco volumes fell by 2.6% last year, the overall market fell by an estimated 3.5%. So by focusing on core growth brands such as Dunhill and Pall Mall, BAT appears to have gained market share.

Next generation products

The group has been one of the biggest investors in next-generation tobacco products. Together with RAI, it has spent $2.5bn since 2012 on vapour and tobacco heating products such as glo.

These — plus snuff products — are becoming an increasingly important part of the business. Next-gen sales totalled £397m in 2017, but are expected to hit £1bn in 2018 and more than £5bn by 2022.

This worries me

It’s not yet clear whether these products will be as profitable as traditional tobacco. BAT’s operating margin was 31.9% last year, cementing its position as one of the most profitable businesses in the FTSE 100.

This is just as well, because it’s also one of the most indebted businesses in the FTSE. Net debt rose by £28.8bn to £45.6bn last year, thanks to the additional borrowings required to complete the Reynolds acquisition.

Historically, BAT’s high margins have enabled the group to generate a lot of surplus cash. I expect this to continue, but I do think that the need to reduce net debt could limit potential dividend growth.

I estimate that the group’s underlying free cash flow was about £4.5bn last year. This was barely enough to cover interest payments (£1.1bn) and dividends (£3.5bn).

Looking ahead, I estimate that a full year of Reynolds ownership could lift free cash flow to about £6bn in 2018. Based on last year’s interest and dividend payments, that only leaves around £1.5bn to repay debt.

Even allowing for some efficiency savings, I think it will take the firm a few years to reduce debt to a more comfortable level. To buy this stock, I’d want to see borrowings reduced to around five times the group’s after-tax profit. That would give a net debt figure of £30bn, around £15bn below current levels.

The shares currently trade on a forecast P/E of 14 with a prospective yield of 4.6%. That’s not cheap enough for me given the group’s debt burden, so I won’t be buying.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »